Anti-Cancer Drugs Flashcards
(51 cards)
Alkylating agents
cyclophosphamide
Cisplatin
Alkylating agents: mode of action
Alkylating agents: mode of action
inhibit DNA synthesis
*works in ANY phase of the cell cycle
Alkylating agents: mechanism of action
physically binding to DNA to stop cell growth
Anti-metabolites
Methotrexate
5-FU
Capecitabine
Anti-metabolites: mode of action
block DNA synth in S phase
Anti-metabolites: mechanism of action
remove critical proteins in DNA replication (methotrexate)
become false substrates for DNA synthetic enzymes (5-fluorouracil & capecitabine)
ie blocking folic acid, purine, pyrimidine
What are the 2 plant alkaloids?
Vincas & Taxenes
Plant metabolites - VINCAS
Vincristine Vinblastine Vinorelbine Vindestine (Vin-)
VINCAS: mode of action
arrest of cell division
VINCAS: mechanism of action
prevent formation of mitotic spindle during the M phase
Plant metabolites - TAXENES
Paclitaxel
Docetaxel
(-taxel)
TAXENES: mode of action
stabilize microtubule assembly to prevent cell division
TAXENES: mechanism of action
spindle forms but cannot come apart during the M phase
Antitumor antibiotics
doxorubicin & epirubicin
-rubicin
Antitumor Antibiotics: Mode of action
Causing DNA strand breaks
Antitumor Antibiotics: Mechanism of Action
Inhibits topoisomerase II (enzyme that unwinds/reseals for synthesis)
*fit in between the strands of DNA - called intercalation
ANTI-ANDROGENS:
bicalutamide, flutamide, nilutamide
-utamide
ANTI-ANDROGENS: MOA
inhibit and/or degrade the androgen receptor
ANTI-ANDORGENS: Use
androgen dependent prostate cancer
KINASE INHIBITORS
erlotinib - EGFR1
lapatinib - EGFR1&2
sutinib - VEGFR/PDGFR
sorafenib - VEGFR/PDGFR
(-nib)
KINASE INHIBITORS EGCR1/2 MOA
on tumor cells
blocks growth factor signaling leads to decreased TUMOR growth and survival
KINASE INHIBITORS-VEGFR & PDGFR MOA
VEGFR - on endothelial cells of blood vessels
PDGFR - on smooth muscle cells of blood vessel
Cane lead to decreased tumor BLOOD VESSEL growth (angiogenesis)
Immune checkpoint inhibitor drugs
CTLA-4 inhibitors:
Ipilumumab
PD-1/OD-1L inhibitors:
1) PD-1 inhibitors: pembrolizumab, nivolumab
2) PD-1L inhibitors: atezolizumab, avelumab
*(-mab)
CTLA-4 inhibitors MOA
blocking CTLA-4 sustains the cytotoxic T cell kill of cancer cells
- enhances the immune system to kill tumors
- acts within the lymph system